Oncology & Cancer
Study suggests way to improve treatment of hereditary breast cancer
PARP inhibitors have improved survival of breast cancer patients with BRCA1/2 mutations, but the drugs eventually stop working and the cancer returns.
Aug 15, 2024
0
28